NVAX--

nvax vaccine markets billions margin income

$NVAX Another tough day. Seems like someone knows something. How about it? Maybe someone realized that Matrix M isn't really a thing? Nope, science says otherwise and vaccine markets are worth billions (with high margin INCOME) in the next 10 years. How about fewer and less important MTA’s? No, there are many, including respiratory and oncology, so that's out. The NVAX CIC is doing well and has shown good results in its latest trials. Just needs a partner to turn into a real product worth billions. Not bad. NANOFLU? Same as CIC. Oh wait- SNY phase three results were bad? No, SNY says phase three is going strong. Management? Mismanagement? Bad deals? Ignoring shareholders? Golly, maybe management IS the issue!

Comments



No comments

No comments yet

Disclaimer: The above is a summary showing certain market information. Ainvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing, All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market.Report an Issue